DAPK1 and early-onset autosomal dominant Alzheimer disease: Since DAPK-1 is essential for the death and loss of neuronal cells under various stimuli, DAPK-1 inhibitors may offer a novel therapeutic strategy for neurological diseases such as ischemia and Alzheimer’s disease [101].